Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (10,5 Mio. €): INTEGRIERTE DIENSTLEISTUNGEN FÜR DIE FORSCHUNG ZU AUSBRÜCHEN VON INFEKTIONSKRANKHEITEN II Hor11.05.2026 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Text

INTEGRIERTE DIENSTLEISTUNGEN FÜR DIE FORSCHUNG ZU AUSBRÜCHEN VON INFEKTIONSKRANKHEITEN II

ISIDORe II (Integrated Services for Infectious Disease Outbreak Research II) represents the strategic continuation of ISIDORe. Building on its proven capacity to mobilise Europe’s research infrastructures (RIs) for pandemic preparedness and response (PP&R) research, ISIDORe II consolidates the model into a leaner, strategically aligned consortium that enhances agility, coherence, and sustainability. Infectious disease–focused RIs form the operational backbone, ensuring depth in epidemic- and pandemic-relevant science, while transversal RIs provide enabling technologies such as imaging, omics, and structural biology. This integrated architecture ensures that Europe’s RI landscape delivers high-quality, challenge-driven, and interoperable services. ISIDORe II pursues three overarching missions: (1) deliver excellent RI services for PP&R research and empower users through a curated service catalogue, an interoperable digital platform, and inclusive outreach; (2) amplify impact by enabling scientific excellence, innovation, and data stewardship, accelerating medical countermeasure (MCM) development, embedding FAIR principles, and aligning with European Open Science policies; and (3) anchor the ISIDORe model within the EU and global preparedness ecosystem through coordination with actors such as HERA, ECDC, WHO, and DURABLE, while developing a stakeholder-validated sustainability plan. By offering a coherent, strategically sharpened model for transnational and virtual access (TNA/VA), ISIDORe II ensures that users benefit from comprehensive support, including ethics, biosafety, and regulatory guidance, alongside interoperable data practices. Its activities generate scientific excellence, policy-relevant evidence, and long-term impact for European and global health security. As the natural continuation of ISIDORe, ISIDORe II transforms a successful pilot into a sustainable cornerstone of the European preparedness and response landscape.


Geförderte Unternehmen:

Firmenname Förderungssumme
Agencia Estatal Consejo Superior de Investigaciones Cientificas 0,00 €
Assistance Publique Hopitaux de Paris 10.000,00 €
Bernhard-Nocht-Institut Fuer Tropenmedizin 0,00 €
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) 245.375 €
Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia 0,00 €
Centre National de la Recherche Scientifique CNRS 0,00 €
Ceske Vysoke Uceni Technicke V Praze 0,00 €
Charite - Universitaetsmedizin Berlin 0,00 €
Consiglio Nazionale Delle Ricerche 0,00 €
Department of Health 0,00 €
Eatris Eric 505.313 €
Ecrin European Clinical Research Infrastructure Network 100.313 €
Eidgenoessisches Departement DES Innern 10.000,00 €
Erasmus Universitair Medisch Centrum Rotterdam 0,00 €
Euro-Bioimaging Eric 325.675 €
European Infrastructure OF Open Screening Platforms FOR Chemical Biology European Research Infrastucture Consortium (EU-Openscreen Eric) 491.250 €
European Molecular Biology Laboratory 295.755 €
European Research Infrastructure ON Highly Pathogenic Agents 5.963.125 €
European Vaccine Initiative e. V. 296.250 €
European Virus Archive Aisbl 634.146 €
Folkhalsomyndigheten 0,00 €
Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit 10.000,00 €
Fundacao Gimm - Gulbenkian Institute For Molecular Medicine 0,00 €
Fundacion Centro de Excelencia en Investigacion de Medicamentos Innovadores en Andalucia 0,00 €
Hellenic Pasteur Institute 0,00 €
Helmholtz-Zentrum FUR Infektionsforschung GmbH 10.000,00 €
Helsingin Yliopisto 0,00 €
Infrafrontier Eric 297.750 €
Institut de Investigacio en Ciencies de La Salut Germans Trias i Pujol 0,00 €
Institut de Recerca i Tecnologia Agroalimentaries 10.000,00 €
Institut National de la Sante et de la Recherche Medicale 0,00 €
Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement 679.983 €
Instituto de Biologia Experimental e Tecnologica 10.000,00 €
Instituto de Salud Carlos III 0,00 €
Instituto Nacional de Saude DR. Ricardo Jorge 0,00 €
Institut Pasteur 0,00 €
Instruct-Eric 511.563 €
Istituto Nazionale Per LE Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico 0,00 €
Istituto Superiore Di Sanita 0,00 €
Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'Emilia Romagna Bruno Ubertini 0,00 €
Istituto Zooprofilattico Sperimentale Delle Venezie 0,00 €
Karolinska Institutet 0,00 €
Katholieke Universiteit Leuven 0,00 €
Latvijas Organiskas Sintezes Instituts 0,00 €
Mediterranee Infection 10.000,00 €
Medizinische Universitat Graz 0,00 €
Nemzeti Nepegeszsegugyi ES Gyogyszereszeti Kozpont 0,00 €
Oslo Universitetssykehus HF 0,00 €
Rijksinstituut Voor Volksgezondheid EN Milieu (Rivm) 0,00 €
Statens Serum Institut 10.000,00 €
Stichting Biomedical Primate Research Center 10.000,00 €
Stichting Wageningen Research 10.000,00 €
The Chancellor, Masters and Scholars of the University of Oxford 0,00 €
The Secretary of State for Environment, Food and Rural Affairs 0,00 €
Universitat Basel 0,00 €
Universite d'AIX Marseille 0,00 €
Universitetet I Tromsoe - Norges Arktiske Universitet 0,00 €
Univerza V Ljubljani 0,00 €
Ustav Molekularni Genetiky AV CR V.V.I. 0,00 €
Vaccine Formulation Institute(CH)Ltd. 10.000,00 €

Quelle: https://cordis.europa.eu/project/id/101293306

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.